Multiple sclerosis: Rationale for early treatment

Neurological Sciences

Volumn 24, Issue SUPPL. 5, 2003, Pages

  Soderstrom M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Interferon beta; MRI; Multiple sclerosis; Oligoclonal bands; Optic neuritis

Indexed keywords

BETA1A INTERFERON; METHYLPREDNISOLONE; PLACEBO;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DEMYELINATION; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; HUMAN; IMMUNOPATHOGENESIS; MEDICAL SPECIALIST; MULTIPLE SCLEROSIS; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGY; OPTIC NERVE DISEASE; PATIENT REFERRAL; TREATMENT OUTCOME;

HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; OPTIC NEURITIS; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS;

EID: 0345602741     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-003-0179-y     Document Type: Article

References (9)

1. The IFNB Multiple Sclerosis Study Group (1993) Interferon-beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicentre, randomized, double-blind, placebo-controlled trial. Neurology 43:655-661
2. Jacobs LD, Cookfair DL, Rudick RA et al (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol 39:285-294
3. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group (1998) Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 352:1498-1504
4. Sandberg-Wollheim M, Bynke H, Cronqvist S, Holtås S, Platz P, Ryder LP (1990) A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 27:386-393
5. O'Riordan JI, Thompson AJ, Kingsley DPE et al (1998) The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 121:495-503
6. Söderström M, Jin YP, Hillert, Link H (1998) Optic neuritis. Prognosis for multiple sclerosis from MRI, CSF and HLA findings. Neurology 50:708-714
7. Ghezzi A, Martinelli V, Torri V et al (1999) Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol 246:770-775
8. Jacobs LD, Beck RW, Simon JH et al (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 343:898-904
9. Comi G, Filippi M, Barkhof F et al (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study. Lancet 357:1576-1582